Skip to main content

Month: July 2021

Agillic raises EBITDA guidance for 2021

Company Announcement no. 14 2021 Copenhagen – 15 July 2021 – Agillic A/S (Nasdaq First North Growth Market Denmark: AGILC), the Copenhagen-based marketing automation Software-as-a-Service (SaaS) company announces, that it has raised its EBITDA guidance.   The gross profit has developed better than expected in the 1st half year due to an improved sales mix effect, as the gross margin is higher on subscriptions than on transactions. The improved sales mix is also expected to continue for the rest of the year. Therefore, Agillic raises its guidance for EBITDA from DKK -5 to -1 million to DKK 0 to 3 million. The guidance on revenue and ARR is maintained. Consequently, the new financial guidance for 2021 is shown in the table below. New financial guidance for 2021 per 15 July 2021DKK million 2021Revenue 49 – 53EBITDA 0 –...

Continue reading

Search Minerals Reports the DEEP FOX Drill Program is Over 50% Completed

VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) — Search Minerals Inc. (TSXV: SMY | OTCQB: SHCMF) (“Search” or the “Company”) is pleased to provide an update on its 7000m drilling program at DEEP FOX, located in our Port Hope Simpson – St. Lewis Critical Rare Earth Elements (CREE) District in SE Labrador, which begun in June 2021. DEEP FOX DRILL PROGRAM UPDATE The drill program commenced June 2, 2021, with our expectation of 7000m of drilling and completion of between 40-45 drill holes.Drilling program objectives:extend the current resource (see Search Minerals News Release, Oct. 1, 2019) to the 200m level with a 50m x 50m grid; drill on a 25 x 25m grid to the 50m level; drill two cross-sections (25m spacing) to the 200m level; and explore to the 250m level.Drilling program progress:completed 3900 m of drilling...

Continue reading

Himax Sponsors tinyML Vision Challenge to Foster tinyML Vision Development

TAINAN, Taiwan, July 15, 2021 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that it sponsored tinyML Vision Challenge, hosted by tinyML Foundation, to advance tinyML computer vision technology into the developer community. A total of $6,000 and extra prizes will be awarded to encourage participants and initiate more machine learning problem solvers from different areas of interest. Himax Supports the tinyML Foundation to Create An Innovative Development Environment tinyML Foundation is a non-profit professional organization focused on supporting and nurturing the fast-growing branch of ultralow power machine learning technologies to deal with machine intelligence for edge devices....

Continue reading

Report 2021, Influenza Vaccine Market Is Projected to Reach USD 10.73 Billion at CAGR of 7.4%

Influenza Vaccine Market Key Players are GlaxoSmithKline plc. (U.K, Europe), Sanofi S.A (France, Europe), AstraZeneca (Cambridge, United Kingdom), Seqirus (Maidenhead, UK) BioDiem (South Melbourne Victoria), Emergent BioSolutions Inc. (Maryland, United States), Sinovac Biotech Ltd (China), Other Prominent Players. Pune, India, July 15, 2021 (GLOBE NEWSWIRE) — According to the report, Global Influenza Vaccine market size is projected to reach USD 10.73 billion value at CAGR of 7.4% during the forecast period 2021 to 2028. The growing regulations about fuel-efficiency and vehicular weight will have a positive impact on the Influenza Vaccine market growth in the forthcoming years The report further mentions that the market stood at USD 5.86 billion in 2020. According to the Centers for Disease Control and Prevention (CDC), around...

Continue reading

Global Nanopharmaceuticals Market 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast Report

Top Players Covered in the Nanopharmaceuticals Market Research Report Are Eli Lilly and Company, Merck & Co., Pfizer Inc., Abbott, AstraZeneca, Johnson & Johnson Services, F. Hoffmann-La, Roche Ltd, Novartis AG, GlaxoSmithKline Plc and other key market players. Pune, India, July 15, 2021 (GLOBE NEWSWIRE) — The global Nanopharmaceuticals Market size is expected to gain momentum due to developing effective therapeutics for pharmaceutical companies during the forecast period. This information is published by Fortune Business Insights™ in an upcoming report, titled, “Nanopharmaceuticals Market, 2021-2028.” The major developments in nanotechnology for pharmaceuticals and the rising prevalence of various diseases such as cardiovascular diseases, neurological diseases, infectious diseases, oncological diseases, orthopaedic diseases,...

Continue reading

Subsea 7 S.A. Q2 2021 results conference call notification

Luxembourg – 15 July 2021 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) will publish its second quarter results for the period ended 30 June 2021 on 28 July 2021 at 07:00 UK time. A conference call and simultaneous webcast for the investment community will be held on 28 July 2021 at 12:00 noon UK time. From 07:00 UK time the results announcement and the presentation to be reviewed on the conference call and webcast will be available on the Subsea 7 website: www.subsea7.com Conference call information:Date:                          28 July 2021Time:                         12:00 UK Time Conference call registration:Registration for phone dial-in: http://emea.directeventreg.com/registration/1977909Registration for webcast: https://edge.media-server.com/mmc/p/cnp995zm       A live webcast and a playback facility will be available on the...

Continue reading

Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuros’s license agreement with Checkmate Pharmaceuticals

Ad hoc announcement pursuant to Article 53 of the SIX listing rules SCHLIEREN (ZURICH), Switzerland, July 15, 2021 (GLOBE NEWSWIRE) — Kuros Biosciences AG (“Kuros” or the “Company”), a leader in next generation bone graft technologies, announced today that it has entered into a royalty purchase agreement with XOMA Corporation (NASDAQ: XOMA) under which XOMA has purchased a proportion of the potential future pre-commercial milestone payments and all the potential royalties due under the existing license agreement between Kuros and Checkmate Pharmaceuticals related to one of Kuros’s assets outside of the bone graft field. Kuros will receive an initial payment of $7 million from XOMA. In addition, Kuros retains the potential to receive up to $24 million in pre-commercial milestones from Checkmate, and is eligible to receive up to...

Continue reading

Proactive news headlines including Mako Gold, Auteco Minerals, Aurumin and Astro Resources

Sydney, July 15, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Mako Gold Ltd (ASX:MKG) has gained a new substantial shareholder in Delphi which has picked up an 8.93% interest in the company. Click here Auteco Minerals Ltd (ASX:AUT) has increased the inferred mineral resource estimate for the Pickle Crow Project in Ontario, Canada, by 71% to 1.7 million ounces of gold. Click here Aurumin Ltd (ASX:AUN) has started drilling at its 100%-owned Mt Dimer Gold Project 120 kilometres northeast of Southern Cross in Western Australia. Click here Predictive Discovery Ltd (ASX:PDI) has been granted a trading halt by ASX with an announcement pending in regard to material exploration results. Click here Astro Resources NL’s (ASX:ARO)...

Continue reading

Fingerprint Cards AB: invitation to the second quarter 2021 results presentation

Fingerprint Cards AB (Fingerprints™) will host a telephone conference and webcast presentation of its second quarter 2021 results, on July 22, 2021 at 09:00 CEST. Fingerprints’ CEO Christian Fredrikson will present the report together with CFO Per Sundqvist in a combined webcast and telephone conference. The presentation will be held in English. Time: Thursday, July 22, 2021 at 09:00 am CEST.Location: combined webcast and telephone conference. The report is available at https://www.fingerprints.com/ The webcast and the presentation material can be accessed through https://edge.media-server.com/mmc/p/ae2ki69u where it is also possible to ask questions. For media and analysts: The telephone conference dial-in is +44 (0) 2071 928000 (international participants) or 08-506 921 80 (Swedish participants). Please state conference ID 1277329. About...

Continue reading

Invitation to UPM’s webcast and press conference on half-year financial report 2021

(UPM, Helsinki, 15 July 2021 at 10:00 EEST) – UPM will publish its half-year financial report 2021 on 22 July 2021 at 09:30-10:00 EEST. After publishing the report will be available on the company website www.upm.com. A webcast and a conference call for analysts and investors in English language begins at 13:15 EEST. UPM’s financial results will be presented by the President and CEO Jussi Pesonen and CFO Tapio Korpeinen. All participants can view the webcast online at www.upm.com or through this link, but participants who wish to ask questions must attend the conference call by dialling a number in the list below: Conference call title: UPM Interim Report for January–June 2021International telephone numbers: Argentina Toll: +54 1152526536Australia Toll: +61 284058549Austria Toll: +43 19287907Bahrain Toll: +973 16199100Belgium Toll: +32...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.